Table S2 from Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment
Year: 2023
Type: other
Abstract: Sixty erlotinib-related aberrant DNA methylation genes in both patients discovered with the the methyl-sensitive cut counting sequencing (MSCC) screening method.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361886548
